GENFIT: Leader of a €2.7 M European-funded EUROTRANSBIO program
Press Release of Bicoll’s OLNORME II partner Genfit SA The OLNORME II Consortium, for which GENFIT is the leader, is focused on the development of a new class of drug candidates for the prevention and treatment of cardiometabolic diseases with …